Company Announcements

Director/PDMR Shareholding

Source: RNS
RNS Number : 9242N
Smith & Nephew Plc
03 February 2021
 

SMITH & NEPHEW PLC

 

3 February 2021

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.

 

Smith & Nephew Global Share Plan 2010 (Performance Share Awards):

 

Name of PDMR

Number of ordinary shares under award granted on 07/03/2018 (shown at maximum)

Number of ordinary shares lapsed under award (shown at maximum)

Bradley Cannon

32,528

24,884

Phil Cowdy

15,494

11,853

Elga Lohler

24,768

18,948

Catheryn O'Rourke

24,548

18,780

Vasant Padmanabhan

                             27,894

21,339

Susan Swabey

10,920

8,354

 

Notes:

 

(i)      Following completion of the performance measurement period, 47% of the target awards made on 7 March 2018 vested.

 

(ii)     At maximum, 76.5% of awards have lapsed on 3 February 2021 and the remaining 23.5% of awards will vest and subject to continued employment, will be settled on 8 March 2021 being the first business date after the third anniversary of the awards.  

 

This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.

 

Vickie Reuben  

Deputy Company Secretary

Smith & Nephew plc

Tel:      +44 (0) 1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFERFEIVIIL